Immunocore (IMCR)
(Delayed Data from NSDQ)
$33.87 USD
+0.47 (1.41%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $33.81 -0.06 (-0.18%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Immunocore Holdings PLC Sponsored ADR (IMCR) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$80.80 | $100.00 | $66.00 | 141.92% |
Price Target
Based on short-term price targets offered by 15 analysts, the average price target for Immunocore Holdings PLC Sponsored ADR comes to $80.80. The forecasts range from a low of $66.00 to a high of $100.00. The average price target represents an increase of 141.92% from the last closing price of $33.40.
Analyst Price Targets (15)
Broker Rating
Immunocore Holdings PLC Sponsored ADR currently has an average brokerage recommendation (ABR) of 1.18 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 17 brokerage firms. The current ABR compares to an ABR of 1.17 a month ago based on 18 recommendations.
Of the 17 recommendations deriving the current ABR, 15 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 88.24% and 5.88% of all recommendations. A month ago, Strong Buy made up 88.89%, while Buy represented 5.56%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/IMCR.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 15 | 15 | 16 | 16 | 16 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.18 | 1.18 | 1.17 | 1.17 | 1.17 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/29/2024 | Robert W. Baird & Co. | Jack K Allen | Strong Buy | Strong Buy |
8/12/2024 | Mizuho SecuritiesUSA | Graig Suvannavejh | Strong Buy | Strong Buy |
8/9/2024 | Cantor Fitzgerald & Co | Eric Schmidt | Strong Buy | Strong Buy |
8/9/2024 | BTIG | Justin R Zelin | Strong Buy | Strong Buy |
8/9/2024 | Needham & Company | Gil J Blum | Moderate Buy | Moderate Buy |
8/9/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/8/2024 | Capital One Securities | Naureen Quibria | Strong Buy | Strong Buy |
8/8/2024 | SVB Securities | Jonathan W Chang | Strong Buy | Strong Buy |
6/5/2024 | H.C. Wainwright & Co. | Patrick Trucchio | Strong Buy | Strong Buy |
6/3/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/23/2024 | Guggenheim Securities | Michael Schmidt | Strong Buy | Strong Buy |
4/1/2024 | Cowen & Co. | Tyler Van Buren | Strong Buy | Strong Buy |
3/15/2024 | Goldman Sachs | Rajan Sharma | Strong Buy | Strong Buy |
2/29/2024 | Canaccord Genuity | William Maughan | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.18 |
ABR (Last week) | 1.18 |
# of Recs in ABR | 17 |
Average Target Price | $80.80 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 86 of 253 |
Current Quarter EPS Est: | -0.43 |
IMCR FAQs
Immunocore Holdings PLC Sponsored ADR (IMCR) currently has an average brokerage recommendation (ABR) of 1.18 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 17 brokerage firms.
The average price target for Immunocore Holdings PLC Sponsored ADR (IMCR) is $80.80. The current on short-term price targets is based on 9 reports.
The forecasts for Immunocore Holdings PLC Sponsored ADR (IMCR) range from a low of $66 to a high of $100. The average price target represents a increase of $138.56 from the last closing price of $33.87.
The current UPSIDE for Immunocore Holdings PLC Sponsored ADR (IMCR) is 138.56%
Based on short-term price targets offered by 15 analysts, the average price target for Immunocore Holdings PLC Sponsored ADR comes to $80.80. The forecasts range from a low of $66.00 to a high of $100.00. The average price target represents an increase of 141.92% from the last closing price of $33.40.